MARKET

VYYRF

VYYRF

Voyageur Pharmaceuticals Ltd
OTCPK
0.120
NaN%
Closed 09:30 03/06 EST
OPEN
--
PREV CLOSE
0.120
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.240
52 WEEK LOW
0.0033
MARKET CAP
21.43M
P/E (TTM)
-8.3333
1D
5D
1M
3M
1Y
5Y
1D
Voyageur Confirms High-Purity Barite, Advances to Health Canada Trial
TipRanks · 4d ago
Voyageur Pharmaceuticals Secures Bayer Collaboration to Advance Iodine Contrast Supply
TipRanks · 02/23 14:35
Voyageur Pharmaceuticals Gains Full Control of Iodine Technology, Names New Director of Chemistry
TipRanks · 01/12 14:18
Voyageur Pharmaceuticals Strengthens Board for U.S. Expansion
TipRanks · 11/07/2025 21:45
Voyageur Pharmaceuticals Expands into Mexican Market with Phalanx Partnership
TipRanks · 10/29/2025 22:11
Voyageur Pharmaceuticals Expands Board with Wall Street Experts for U.S. Market Growth
TipRanks · 10/23/2025 22:39
Weekly Report: what happened at VYYRF last week (0908-0912)?
Weekly Report · 09/15/2025 09:39
Weekly Report: what happened at VYYRF last week (0901-0905)?
Weekly Report · 09/08/2025 09:40
More
About VYYRF
Voyageur Pharmaceuticals Ltd. is a Canada-based company engaged in the development of barium and iodine active pharmaceutical ingredients (API) and imaging contrast agents for medical radiology. It focuses on vertically integrating the barium and iodine contrast markets. In addition, Voyageur is pursuing the development of new endo fullerene drugs. Its products include SmoothX, SmoothHD, SmoothLD, VisionHD, VisionLD and V-Gas. SmoothX (2%w/v) is a contrast medium for use in computed tomography (CT) of the gastrointestinal tract. VisionHD is a high-density (98% w/w) barium powder suspension tailored for double-contrast radiographic examination of the gastrointestinal tract, esophagus, stomach and duodenum. At the core of its operations, the Company also owns a 100% interest in the Frances Creek Project, which boasts a mineral suitable for the pharmaceutical marketplace that is intended to replace the current synthetic products with quality imaging products.

Webull offers Voyageur Pharmaceuticals Ltd stock information, including OTCPK: VYYRF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VYYRF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VYYRF stock methods without spending real money on the virtual paper trading platform.